Galectin-4 and Intestinal Inflammation
Author Information
Author(s): Paclik Daniela, Danese Silvio, Berndt Uta, Wiedenmann Bertram, Dignass Axel, Sturm Andreas
Primary Institution: Charité-Universitätsmedizin Berlin
Hypothesis
Galectin-4 plays a unique role in controlling intestinal inflammation by regulating T cell apoptosis and cell cycle.
Conclusion
Galectin-4 is a potential therapeutic agent for inflammatory bowel disease due to its ability to induce T cell apoptosis and reduce inflammation.
Supporting Evidence
- Galectin-4 is selectively expressed and secreted by intestinal epithelial cells.
- Galectin-4 binding inhibits T cell activation and reduces pro-inflammatory cytokine secretion.
- Galectin-4 treatment significantly ameliorated symptoms of experimental colitis in mice.
Takeaway
Galectin-4 helps calm down inflammation in the intestines by making certain immune cells die when they shouldn't be active.
Methodology
The study involved immunohistochemical staining, flow cytometry, and animal models to assess the effects of Galectin-4 on T cell function and inflammation.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website